Chugai Pharmaceutic-Unsp ADRCHGCY

13F holders, Q1 2025 (March 31)
11holders +4
4new positions
0sold out
$22.74avg. 13F price*

At the end of Q1 2025, 11 institutions reported holding Chugai Pharmaceutic-Unsp ADR (CHGCY) in their 13F filings, up 4 from Q4 2024. 4 opened new positions and 0 sold out. The largest holders were Sterling Capital Management LLC ($1.6M), Confluence Investment Management LLC ($885K) and Rhumbline Advisers ($624K).

Company
Chugai Pharmaceutic-Unsp ADR
CUSIP
171269103
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q1 2024: 9Q1 2024Q2 2024: 6Q2 2024Q3 2024: 8Q3 2024Q4 2024: 7Q4 2024Q1 2025: 11Q1 2025Q2 2025: 12Q2 2025Q3 2025: 8Q3 2025Q4 2025: 13Q4 2025Q1 2026: 13Q1 2026Q2 2026: 12Q2 2026

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions4$274K
Exits0$0

All 13F filers, Q4 2024 → Q1 2025: 19,327 shares bought and 1,557 shares sold, net +17,770 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 11 holders

Sterling Capital Management LLC 0.03% Add +7.9% 71,963 $1.6M
Confluence Investment Management LLC 0.01% Add +0.9% 38,924 $885K
Rhumbline Advisers 0.00% Reduce -3.1% 27,434 $624K
PNC Financial Services Group, Inc. 0.00% Reduce -4.2% 13,399 $305K
Riverbridge Partners LLC 0.00% New 10,870 $247K
GAMMA Investing LLC 0.02% Add +20.1% 9,874 $225K
Brooklyn Investment Group 0.01% Reduce -4.8% 1,506 $34K
Hantz Financial Services, Inc. 0.00% New 516 $12K
Accent Capital Management, LLC 0.01% New 400 $9K
Thurston, Springer, Miller, Herd & Titak, Inc. 0.00% New 256 $6K
Richardson Financial Services Inc. 0.00% Add +100.0% 28 $637

"% of holder's portfolio" is CHGCY's weight in each manager's 13F, not the share of Chugai Pharmaceutic-Unsp ADR the manager owns.